GO
  • Home
  • About CReATe
  • +For Patients and Friends
    • Studies
    • CReATe Podcasts
    • ALS Research Paper Review
    • Brain Donation
    • Additional Resources
    • Patient Advocacy Groups
  • +For Researchers
    • CReATe Biorepository
    • Original Content Articles
    • Publications
    • Scholarship Program
  • News
  • Contact Us
  • RDCRN
CReATe
  GO
  • Home
  • About CReATe
  • For Patients and Friends
    • Studies
    • CReATe Podcasts
    • ALS Research Paper Review
    • Brain Donation
    • Additional Resources
    • Patient Advocacy Groups
  • For Researchers
    • CReATe Biorepository
    • Original Content Articles
    • Publications
    • Scholarship Program
  • News
  • Contact Us
  • RDCRN
CReATe
|
Login
CReATe  
|
Login

News

  News
  • Clinical Research Training Scholarship in ALS and Related Disorders
  • 2020 Request for Applications: Biomarker Development/Validation for CReATe (Clinical Research in ALS and Related Disorders for Therapeutic Development)
  • ALS Biomarkers Review Calls for Consortium to Speed Progress (1-5-16)

 

 
Copyright (c) 2023 CReATe | Privacy Statement | Terms Of Use

Website Policies   |   Member Site Login   |   Rare Diseases Clinical Research Network

The Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). CReATe is funded under grant number U54NS092091 as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818.